Amneal Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03168L1052

Introduction

This page provides a comprehensive analysis of the known insider trading history of Vergis Janet S.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Vergis Janet S. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:XRAY / DENTSPLY SIRONA Inc. Director 44,121
US:CHD / Church & Dwight Co., Inc. Director 17,102
US:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Director 73,697
US:AMRX / Amneal Pharmaceuticals, Inc. Director 0
US:IPXL / Impax Laboratories, Inc. Director 0
Director 3,751
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Vergis Janet S.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases AMRX / Amneal Pharmaceuticals, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in AMRX / Amneal Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

AMRX / Amneal Pharmaceuticals, Inc. Insider Trades
Insider Sales AMRX / Amneal Pharmaceuticals, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in AMRX / Amneal Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

AMRX / Amneal Pharmaceuticals, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Vergis Janet S. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-07-15 2025-07-11 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 139 44,121 0.32
2025-07-08 2025-06-30 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 729 17,102 4.45 96.11 70,064 1,643,673
2025-06-09 2025-06-06 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 9,632 73,697 15.03
2025-05-27 2025-05-22 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 13,880 43,981 46.11
2025-05-06 2025-05-02 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 860 860
2025-04-15 2025-04-11 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 87 30,101 0.29
2025-01-14 2025-01-10 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 68 30,014 0.23
2024-10-15 2024-10-11 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 48 29,945 0.16
2024-07-15 2024-07-12 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 51 29,898 0.17
2024-07-02 2024-06-30 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 676 16,373 4.31 103.68 70,088 1,697,553
2024-06-17 2024-06-15 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 21,108 64,065 49.14
2024-05-24 2024-05-23 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 7,994 29,847 36.58
2024-05-06 2024-05-03 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 750 750
2024-04-15 2024-04-12 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 26 21,853 0.12
2024-01-16 2024-01-12 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 21 21,826 0.10
2023-10-16 2023-10-13 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 49 21,805 0.22
2023-08-07 2023-08-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 15,810 42,957 58.24
2023-07-17 2023-07-14 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 41 21,756 0.19
2023-07-03 2023-06-30 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 699 15,697 4.66 100.23 70,061 1,573,310
2023-05-26 2023-05-25 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 5,419 21,714 33.25
2023-05-01 2023-04-28 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 820 820
2023-04-18 2023-04-14 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 23 16,295 0.14
2023-01-13 2023-01-13 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 25 16,273 0.15
2022-11-16 2022-11-15 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 6,382 16,248 64.69
2022-07-01 2022-06-30 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 648 14,998 4.52 92.66 60,044 1,389,715
2022-06-16 2022-06-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 14,479 27,147 114.30
2022-04-11 2022-04-08 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 8 9,866 0.08
2022-01-19 2022-01-14 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 6 9,858 0.06
2021-10-12 2021-10-08 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 6 9,852 0.06 60.01 331 591,219
2021-07-13 2021-07-09 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 5 9,846 0.05 64.18 331 631,947
2021-07-01 2021-06-30 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 1,409 14,350 10.89 85.22 120,075 1,222,907
2021-06-16 2021-06-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 14,479 14,479
2021-06-15 2021-06-14 4 CHD CHURCH & DWIGHT CO INC /DE/
Stock Option
A - Award 7,850 7,850
2021-06-10 2021-06-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -12,668 0 -100.00
2021-06-10 2021-06-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 12,668 12,668
2021-06-01 2021-05-27 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 3,008 9,841 44.02
2021-04-12 2021-04-09 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 8 6,833 0.11
2021-01-12 2021-01-08 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 9 6,826 0.14
2020-10-13 2020-10-09 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 16 6,816 0.23
2020-08-05 2020-08-04 4 CHD CHURCH & DWIGHT CO INC /DE/
Stock Option
M - Exercise -14,660 0 -100.00
2020-08-05 2020-08-04 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
S - Sale -14,660 12,941 -53.11 95.58 -1,401,269 1,236,959
2020-08-05 2020-08-04 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
M - Exercise 14,660 27,601 113.28 41.92 614,474 1,156,896
2020-07-10 2020-07-10 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 16 6,801 0.23
2020-07-01 2020-06-30 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 1,553 12,941 13.64 77.30 120,047 1,000,339
2020-06-16 2020-06-15 4 CHD CHURCH & DWIGHT CO INC /DE/
Stock Option
A - Award 10,950 10,950
2020-06-11 2020-06-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 12,668 12,668
2020-06-11 3 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
0
2020-05-22 2020-05-21 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 4,766 6,785 236.08
2020-04-14 2020-04-10 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 5 2,019 0.26
2020-01-14 2020-01-10 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 4 2,014 0.18
2019-12-13 2019-12-11 4 XRAY DENTSPLY SIRONA Inc.
Common Stock
A - Award 2,010 2,010
2019-11-06 2019-11-05 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
P - Purchase 300 11,388 2.71 67.19 20,158 765,204
2019-07-01 2019-06-28 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 753 11,088 7.29 73.06 55,014 810,089
2019-06-18 2019-06-17 4 CHD CHURCH & DWIGHT CO INC /DE/
Stock Option
A - Award 8,600 8,600
2019-05-08 2019-05-08 4 AMRX Amneal Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -6,107 0 -100.00
2019-05-08 2019-05-08 4 AMRX Amneal Pharmaceuticals, Inc.
Class A Common Stock
M - Exercise 6,107 18,257 50.26
2019-05-08 2019-05-06 4 AMRX Amneal Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 6,459 6,459
2019-05-08 2019-05-06 4 AMRX Amneal Pharmaceuticals, Inc.
Stock Option
A - Award 28,044 28,044
2018-11-06 2018-11-06 4 CHD CHURCH & DWIGHT CO INC /DE/
Stock Option
M - Exercise -15,762 0 -100.00
2018-11-06 2018-11-06 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
S - Sale -15,762 10,335 -60.40 66.54 -1,048,734 687,645
2018-11-06 2018-11-06 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
M - Exercise 15,762 26,097 152.51 34.04 536,460 888,211
2018-07-03 2018-06-29 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 2,070 10,335 25.05 53.16 110,041 549,409
2018-06-19 2018-06-18 4 CHD CHURCH & DWIGHT CO INC /DE/
Stock Option
A - Award 13,200 13,200
2018-05-08 2018-05-04 4 IPXL Impax Laboratories, LLC
Stock Option (Right to Buy)
D - Sale to Issuer -8,100 0 -100.00
2018-05-08 2018-05-04 4 IPXL Impax Laboratories, LLC
Stock Option (Right to Buy)
D - Sale to Issuer -10,575 0 -100.00
2018-05-08 2018-05-04 4 IPXL Impax Laboratories, LLC
Stock Option (Right to Buy)
D - Sale to Issuer -10,575 0 -100.00
2018-05-08 2018-05-04 4 IPXL Impax Laboratories, LLC
Restricted Common Stock
D - Sale to Issuer -5,508 0 -100.00
2018-05-08 2018-05-04 4 IPXL Impax Laboratories, LLC
Common Stock
D - Sale to Issuer -6,642 0 -100.00
2018-05-08 2018-05-07 4 AMRX Amneal Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 6,107 6,107
2018-05-08 2018-05-07 4 AMRX Amneal Pharmaceuticals, Inc.
Stock Option
A - Award 24,977 24,977
2018-05-08 2018-05-04 4 AMRX Amneal Pharmaceuticals, Inc.
Stock Option
A - Award 8,100 8,100
2018-05-08 2018-05-04 4 AMRX Amneal Pharmaceuticals, Inc.
Stock Option
A - Award 10,575 10,575
2018-05-08 2018-05-04 4 AMRX Amneal Pharmaceuticals, Inc.
Stock Option
A - Award 10,575 10,575
2018-05-08 2018-05-04 4 AMRX Amneal Pharmaceuticals, Inc.
Class A Common Stock
A - Award 12,150 12,150
2017-07-05 2017-06-30 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 2,121 8,265 34.52 51.88 110,037 428,788
2017-06-20 2017-06-19 4 CHD CHURCH & DWIGHT CO INC /DE/
Stock Option
A - Award 11,590 11,590
2017-05-17 2017-05-16 4 IPXL IMPAX LABORATORIES INC
Stock Option (Right-to-Buy)
A - Award 10,575 10,575
2017-05-17 2017-05-16 4 IPXL IMPAX LABORATORIES INC
Common Stock
A - Award 4,375 12,150 56.27
2016-07-01 2016-06-30 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 972 3,072 46.29 102.89 100,009 316,078
2016-06-30 2016-06-20 4/A CHD CHURCH & DWIGHT CO INC /DE/
Stock Option
A - Award 6,480 6,480
2016-06-21 2016-06-20 4 CHD CHURCH & DWIGHT CO INC /DE/
Stock Option
A - Award 6,479 6,479
2016-05-19 2016-05-17 4 IPXL IMPAX LABORATORIES INC
Stock Option (Right to Buy)
A - Award 10,575 10,575
2016-05-19 2016-05-17 4 IPXL IMPAX LABORATORIES INC
Common Stock
A - Award 4,375 7,775 128.68
2015-10-09 2015-10-07 4 IPXL IMPAX LABORATORIES INC
Stock Option (Right to Buy)
A - Award 8,100 8,100
2015-10-09 2015-10-07 4 IPXL IMPAX LABORATORIES INC
Common Stock
A - Award 3,400 3,400
2015-09-02 2015-09-02 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
P - Purchase 1,000 2,100 90.91 84.82 84,820 178,122
2015-07-02 2015-06-30 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 617 1,100 127.74 81.13 50,057 89,243
2015-06-24 2015-06-22 4 CHD CHURCH & DWIGHT CO INC /DE/
Stock Option
A - Award 7,330 7,330
2014-07-01 2014-06-30 4 CHD CHURCH & DWIGHT CO INC /DE/
Common Stock
A - Award 483 483 69.95 33,786 33,786
2014-05-02 2014-05-01 4 CHD CHURCH & DWIGHT CO INC /DE/
Stock Option
A - Award 7,881 7,881
2013-11-01 2013-10-30 4 KVA/KVB K-V Pharmaceutical Co
Restricted Stock
A - Award 3,751 3,751
2013-11-01 2013-10-30 4 KVA/KVB K-V Pharmaceutical Co
Option to Purchase
A - Award 5,000 5,000
2013-11-01 2013-10-30 4 KVA/KVB K-V Pharmaceutical Co
Option to Purchase
A - Award 15,000 15,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)